Formulation and special investigations of innovative intraoral solid dosage forms.
During our work, we summarized the types of solid dosage forms which were in the focus of attention in the last years because of their innovative pharmaceutical technology solution and simple use. The biopharmaceutics of solid dosage forms for intraoral use and the advantages of the use of these dosages forms were presented in general. However, these dosage forms cannot always be prepared with conventional pharmaceutical processes, therefore the special pharmaceutical solutions which can be applied for their preparation were presented. In addition to testing the European Pharmacopoeia dosage forms, the special tests which can be applied for the characterization of innovative solid dosage forms were highlighted.
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2016 |
|---|---|
| Erschienen: |
2016 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:86 |
|---|---|
| Enthalten in: |
Acta pharmaceutica Hungarica - 86(2016), 3 vom: 22., Seite 99-111 |
| Sprache: |
Ungarisch |
|---|
| Weiterer Titel: |
Not available |
|---|
| Beteiligte Personen: |
Kristo, K [VerfasserIn] |
|---|
| Themen: |
Dosage Forms |
|---|
| Anmerkungen: |
Date Completed 02.04.2018 Date Revised 02.04.2018 published: Print Citation Status MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM281469377 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM281469377 | ||
| 003 | DE-627 | ||
| 005 | 20231225031717.0 | ||
| 007 | tu | ||
| 008 | 231225s2016 xx ||||| 00| ||hun c | ||
| 028 | 5 | 2 | |a pubmed24n0938.xml |
| 035 | |a (DE-627)NLM281469377 | ||
| 035 | |a (NLM)29489081 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a hun | ||
| 100 | 1 | |a Kristo, K |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Formulation and special investigations of innovative intraoral solid dosage forms. |
| 246 | 3 | 3 | |a Not available |
| 264 | 1 | |c 2016 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a Date Completed 02.04.2018 | ||
| 500 | |a Date Revised 02.04.2018 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a During our work, we summarized the types of solid dosage forms which were in the focus of attention in the last years because of their innovative pharmaceutical technology solution and simple use. The biopharmaceutics of solid dosage forms for intraoral use and the advantages of the use of these dosages forms were presented in general. However, these dosage forms cannot always be prepared with conventional pharmaceutical processes, therefore the special pharmaceutical solutions which can be applied for their preparation were presented. In addition to testing the European Pharmacopoeia dosage forms, the special tests which can be applied for the characterization of innovative solid dosage forms were highlighted | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 7 | |a Dosage Forms |2 NLM | |
| 650 | 7 | |a Pharmaceutical Preparations |2 NLM | |
| 700 | 1 | |a kATONA, B |e verfasserin |4 aut | |
| 700 | 1 | |a Piukovics, P |e verfasserin |4 aut | |
| 700 | 1 | |a Olah, I |e verfasserin |4 aut | |
| 700 | 1 | |a Sipos, B |e verfasserin |4 aut | |
| 700 | 1 | |a Sipos, S E |e verfasserin |4 aut | |
| 700 | 1 | |a Sovany, T |e verfasserin |4 aut | |
| 700 | 1 | |a Hodi, K |e verfasserin |4 aut | |
| 700 | 1 | |a Ifi Regdon, G |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Acta pharmaceutica Hungarica |d 1965 |g 86(2016), 3 vom: 22., Seite 99-111 |w (DE-627)NLM000024872 |x 0001-6659 |7 nnns |
| 773 | 1 | 8 | |g volume:86 |g year:2016 |g number:3 |g day:22 |g pages:99-111 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 86 |j 2016 |e 3 |b 22 |h 99-111 | ||